0001064901-19-000001.txt : 20190529
0001064901-19-000001.hdr.sgml : 20190529
20190529162654
ACCESSION NUMBER: 0001064901-19-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190524
FILED AS OF DATE: 20190529
DATE AS OF CHANGE: 20190529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAY CHRISTINA
CENTRAL INDEX KEY: 0001064901
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31668
FILM NUMBER: 19862342
MAIL ADDRESS:
STREET 1: C/O 225 LONG AVENUE
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC
CENTRAL INDEX KEY: 0001016504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222407475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
BUSINESS PHONE: 9739260816
MAIL ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC
DATE OF NAME CHANGE: 20020912
FORMER COMPANY:
FORMER CONFORMED NAME: CHEM INTERNATIONAL INC
DATE OF NAME CHANGE: 19960716
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-05-24
0
0001016504
INTEGRATED BIOPHARMA INC
inbp.ob
0001064901
KAY CHRISTINA
C/O INTEGRATED BIOPHARMA, INC.
225 LONG AVENUE
HILLSIDE
NJ
07205
1
1
0
0
Co-Chief Executive Officer
Stock Option (right to buy)
0.21
2019-05-24
4
A
0
250000
0
A
2029-05-24
Common Stock
250000
250000
D
The option vests 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020.
/S/ Christina Kay
2019-05-29